文献速递瓣膜外科

肥厚型心肌病合并感染性心内膜炎的外科治疗

Surgical Management of Hypertrophic Cardiomyopathy Complicated by Infective Endocarditis.
PubMed 文献 · Ann Thorac Surg · 2022-02-01

单中心回顾分析1995年12月至2018年9月43例肥厚型心肌病合并自体瓣膜感染性心内膜炎的手术患者,95%行室间隔心肌切除术,58%同期瓣膜手术,流出道压差中位数从67 mmHg降至9 mmHg,住院死亡1例,5年与10年累积再手术率分别为11%和26%,总体生存概率分别为94%和78%。

要点

  • 感染性心内膜炎使肥厚型心肌病外科管理复杂化,同期瓣膜修复、人工瓣膜置换和再手术需求增加。
  • 43例中95%(41例)行室间隔心肌切除术,58%(25例)同期瓣膜手术,28%(12例)行人工瓣膜置换。
  • 流出道压差中位数从67 mmHg(四分位距34至97 mmHg)改善至9 mmHg(四分位距6至22 mmHg)。

核心结论

  • 感染性心内膜炎的瓣膜并发症增加了肥厚型心肌病外科管理的复杂性,同期瓣膜修复、人工瓣膜置换和再手术需求增加。
  • 作者强调需要识别感染,尤其是口腔操作后发生的感染,因多数活动性感染性心内膜炎病例之前有口腔操作。

研究设计与样本

  • 单中心回顾性分析,1995年12月至2018年9月在本机构因肥厚型心肌病合并自体瓣膜感染性心内膜炎接受心脏手术的43例患者,数据取自病历记录。

主要发现

  • 中位年龄57岁(四分位距45至67岁),男性81%(35例)。
  • 手术时感染性心内膜炎活动者占21%(9例),其中疑似感染来源为口腔牙源性者占19%(8例)。
  • 显著二尖瓣反流占54%(23例),主动脉瓣反流占7%(3例)。
  • 95%(41例)行室间隔心肌切除术,58%(25例)同期瓣膜手术,其中28%(12例)行人工瓣膜置换;2例未行室间隔心肌切除术而行双瓣膜置换。
  • 流出道压差中位数从67 mmHg(四分位距34至97 mmHg)改善至9 mmHg(四分位距6至22 mmHg);住院死亡1例,原因为不可控肺水肿;截至末次随访7例需再手术,5年和10年累积再手术率分别为11%和26%;死亡10例,5年和10年总体生存概率分别为94%和78%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infective endocarditis is a serious complication in hypertrophic cardiomyopathy. Cardiac surgery is often necessary, however, literature assessing surgical outcomes is limited. METHODS: From December 1995 to September 2018, 43 patients with a history of hypertrophic cardiomyopathy and native valve infective endocarditis underwent cardiac surgery at our institution. Relevant data were abstracted from medical records and analyzed. RESULTS: Median age was 57 years (interquartile range, 45 to 67); 81% (n = 35) were male. Infective endocarditis was active in 21% of patients (n = 9) at the time of surgery; of these, the suspected origin of infection was orodental in 19% (n = 8). Significant mitral valve regurgitation was detected in 54% of patients (n = 23), and aortic valve regurgitation in 7% (n = 3). Septal myectomy was performed in 95% of patients (n = 41), with concomitant valve surgery in 58% (n = 25), including prosthetic replacement in 28% (n = 12). Two patients underwent double valve replacement without septal myectomy. Outflow gradients improved from a median 67 mm Hg (interquartile range, 34 to 97 mm Hg) to 9 mm Hg (interquartile range, 6 to 22 mm Hg). One inhospital death occurred because of uncontrollable pulmonary edema. As of last follow-up, 7 patients required reoperation, and the 5-year and 10-year cumulative incidences were 11% and 26%, respectively. Ten deaths occurred; overall survival probability at 5 and 10 years was 94% and 78%, respectively. CONCLUSIONS: Valvular complications of infective endocarditis add complexity to surgical management of hypertrophic cardiomyopathy. There is an increased need for concomitant valve repairs, prosthetic replacements, and reoperation. These data underscore the need for recognition of infection, especially after oral procedures, which preceded the majority of the active infective endocarditis cases.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Oberoi M, Schaff HV, Nishimura RA, et al. Surgical Management of Hypertrophic Cardiomyopathy Complicated by Infective Endocarditis. Ann Thorac Surg. 2022. PMID: 35120877. doi:10.1016/j.athoracsur.2022.01.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。